Akero Therapeutics, Inc.

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/7/25	→
10-Q	Q2 2025	6/30/25	8/8/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	2/28/25	→
10-Q	Q3 2024	9/30/24	11/8/24	→
10-Q	Q2 2024	6/30/24	8/9/24	→
↓

Earnings Releases (8-K)

27 shown

Filed	Period
8/8/25	Q3 FY2025	→
5/12/25	Q2 FY2025	→
2/28/25	Q1 FY2025	→
1/27/25	Q4 FY2025	→
11/8/24	Q4 FY2024	→
8/9/24	Q3 FY2024	→
↓

News (8-K)

48 shown

Filed	Type	Description
12/9/25	Delisting	Termination of a Material Definitive Agreement	→
12/3/25	Vote	Submission of Matters to a Vote of Security Holders	→
10/9/25	Agreement	Entry into a Material Definitive Agreement	→
9/29/25	Other	Termination of a Material Definitive Agreement	→
6/4/25	Vote	Submission of Matters to a Vote of Security Holders	→
1/30/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

38 shown

Filed	Form	Description
12/9/25	S-8 POS	S-8 POS	→
12/9/25	S-8 POS	S-8 POS	→
12/9/25	S-8 POS	S-8 POS	→
12/9/25	S-8 POS	S-8 POS	→
12/9/25	S-8 POS	S-8 POS	→
12/9/25	S-8 POS	S-8 POS	→
↓

Filing History(734 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 17, 2026

0001274173-26-000064

—

11.8 KB

SCHEDULE 13G/A

Feb 17, 2026

0001493215-26-000022

—

9.8 KB

SCHEDULE 13G/A

Feb 13, 2026

0001172661-26-000709

—

11.0 KB

SCHEDULE 13G/A

Feb 10, 2026

0000902219-26-000090

—

14.9 KB

15-12G

Dec 19, 2025

0001140361-25-04618915-12G

—

12.4 KB

25-NSE

Dec 9, 2025

0001354457-25-001233

—

2.9 KB

Dec 9, 2025

0001193125-25-3121344

Dec 9, 2025

14.5 KB

Dec 9, 2025

0001193125-25-3121334

Dec 9, 2025

16.5 KB

Dec 9, 2025

0001193125-25-3121314

Dec 9, 2025

35.8 KB

Dec 9, 2025

0001193125-25-3121274

Dec 9, 2025

21.9 KB

Dec 9, 2025

0001193125-25-3121224

Dec 9, 2025

12.4 KB

Dec 9, 2025

0001193125-25-3121214

Dec 9, 2025

14.5 KB

Dec 9, 2025

0001193125-25-3121164

Dec 9, 2025

29.9 KB

Dec 9, 2025

0001193125-25-3121154

Dec 9, 2025

22.5 KB

Dec 9, 2025

0001193125-25-3121114

Dec 9, 2025

14.2 KB

Dec 9, 2025

0001193125-25-3121094

Dec 9, 2025

39.7 KB

Dec 9, 2025

0001193125-25-3121004

Dec 9, 2025

25.9 KB

Dec 9, 2025

0001193125-25-3120994

Dec 9, 2025

20.1 KB

Dec 9, 2025

0001193125-25-3120984

Dec 9, 2025

18.5 KB

Dec 9, 2025

0001193125-25-3120924

Dec 9, 2025

35.0 KB

S-8 POS

Dec 9, 2025

0001140361-25-044963S-8 POS

—

31.5 KB

S-8 POS

Dec 9, 2025

0001140361-25-044962S-8 POS

—

31.5 KB

S-8 POS

Dec 9, 2025

0001140361-25-044961S-8 POS

—

31.5 KB

S-8 POS

Dec 9, 2025

0001140361-25-044960S-8 POS

—

31.5 KB

S-8 POS

Dec 9, 2025

0001140361-25-044959S-8 POS

—

31.5 KB

25 filings shown

Filed	Form	Description
11/24/25	DEFA14A	DEFA 14A	→
11/7/25	DEFM14A	DEFM14A	→
10/24/25	PREM14A	PREM14A	→
10/9/25	DEFA14A	DEFA14A	→
10/9/25	DEFA14A	DEFA14A	→
4/28/25	DEF 14A	DEF 14A	→
↓

Akero Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(734 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/13/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/10/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
12/19/25	15-12G	15-12G	→
12/9/25	25-NSE	25-NSE	→
↓